Within a longer observation period of 12 months, patients with therapy modifications slightly increased to 61% for poorly controlled blood pressure, 33% for poorly controlled LDL-cholesterol level, and 85% for poorly controlled HbA1c.
Surface modification, however, slightly increased the surface area.
The perovskite grains with the GO modification seem slightly larger and more uniform in the high-resolution SEM images.
At the late ARS603 this histone modification showed slightly lower levels in G1 and stayed at approximately the same level throughout the time of analysis in this experiment, indicating possible transient cell-cycle specific differences in K36me3 between the two strains.
Sialylation is a relatively low-abundance terminal modification, though slightly more prominent than in the comparable basophil sample (n = 1 3).
As previously observed [ 16, 17], the kinetic signatures for a given modification varied slightly depending on the surrounding sequence context.
In our study, the frequency of HLA-B*35:05 among those who experienced rash-related regimen modification was slightly lower than that in previous study investigated all rash regardless of regimen modification.
This is reflected by HR and HR (ECG) appearing co-clustered, while the patterns of PR intervals modifications are slightly more distinct (correlation with HR: r = −0.67, p = 7×10−5).
These modifications were slightly reduced when telomeric silencing was compromised.
Estimates from the other recursive models (RMM2 and RMM3) also suggested that the correlation changes across categories of GL, including a modification of sign: slightly negative in the first two categories of GL (-0.10 and -0.05, respectively), nil in the third, and slightly positive in the fourth (0.06).
